415 related articles for article (PubMed ID: 27654963)
1. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
[TBL] [Abstract][Full Text] [Related]
2. The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis.
van Dalen SCM; Kruisbergen NNL; Walgreen B; Helsen MMA; Slöetjes AW; Cremers NAJ; Koenders MI; van de Loo FAJ; Roth J; Vogl T; Blom AB; van der Kraan PM; van Lent PLEM; van den Bosch MHJ
Osteoarthritis Cartilage; 2018 Dec; 26(12):1722-1732. PubMed ID: 30195046
[TBL] [Abstract][Full Text] [Related]
3. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels.
Schelbergen RF; van Dalen S; ter Huurne M; Roth J; Vogl T; Noël D; Jorgensen C; van den Berg WB; van de Loo FA; Blom AB; van Lent PL
Osteoarthritis Cartilage; 2014 Aug; 22(8):1158-66. PubMed ID: 24928317
[TBL] [Abstract][Full Text] [Related]
4. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
5. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C
Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM
Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686
[TBL] [Abstract][Full Text] [Related]
6. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
[TBL] [Abstract][Full Text] [Related]
7. IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology.
van Dalen SCM; Blom AB; Walgreen B; Slöetjes AW; Helsen MMA; Geven EJW; Ter Huurne M; Vogl T; Roth J; van de Loo FAJ; Koenders MI; Casteilla L; van der Kraan PM; van den Bosch MHJ; van Lent PLEM
Front Immunol; 2019; 10():1075. PubMed ID: 31191517
[No Abstract] [Full Text] [Related]
8. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis.
Schelbergen RF; Geven EJ; van den Bosch MH; Eriksson H; Leanderson T; Vogl T; Roth J; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; Blom AB; van Lent PL
Ann Rheum Dis; 2015 Dec; 74(12):2254-8. PubMed ID: 25969431
[TBL] [Abstract][Full Text] [Related]
10. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.
Schelbergen RF; de Munter W; van den Bosch MH; Lafeber FP; Sloetjes A; Vogl T; Roth J; van den Berg WB; van der Kraan PM; Blom AB; van Lent PL
Ann Rheum Dis; 2016 Jan; 75(1):218-25. PubMed ID: 25180294
[TBL] [Abstract][Full Text] [Related]
11. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
[TBL] [Abstract][Full Text] [Related]
13. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
Geven EJ; van den Bosch MH; Di Ceglie I; Ascone G; Abdollahi-Roodsaz S; Sloetjes AW; Hermann S; Schäfers M; van de Loo FA; van der Kraan PM; Koenders MI; Foell D; Roth J; Vogl T; van Lent PL
Arthritis Res Ther; 2016 Oct; 18(1):247. PubMed ID: 27776554
[TBL] [Abstract][Full Text] [Related]
14. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
[TBL] [Abstract][Full Text] [Related]
15. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.
Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K
Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
[TBL] [Abstract][Full Text] [Related]
17. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.
Wähämaa H; Schierbeck H; Hreggvidsdottir HS; Palmblad K; Aveberger AC; Andersson U; Harris HE
Arthritis Res Ther; 2011 Aug; 13(4):R136. PubMed ID: 21871094
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Role of Interleukin-1 Pathway in Osteoarthritis: Interleukin-1α and -1β, and NLRP3 Inflammasome Are Not Involved in the Pathological Features of the Murine Menisectomy Model of Osteoarthritis.
Nasi S; Ea HK; So A; Busso N
Front Pharmacol; 2017; 8():282. PubMed ID: 28659793
[No Abstract] [Full Text] [Related]
19. WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis.
van den Bosch MH; Blom AB; Kram V; Maeda A; Sikka S; Gabet Y; Kilts TM; van den Berg WB; van Lent PL; van der Kraan PM; Young MF
Osteoarthritis Cartilage; 2017 Nov; 25(11):1900-1911. PubMed ID: 28735021
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
